These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 28444687

  • 1. Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.
    Crowder LA, Schonberger LB, Dodd RY, Steele WR.
    Transfusion; 2017 Aug; 57(8):1875-1878. PubMed ID: 28444687
    [Abstract] [Full Text] [Related]

  • 2. Absence of evidence of transfusion transmission risk of Creutzfeldt-Jakob disease in the United States: Results froma 28-year lookback study.
    Crowder LA, Dodd RY, Schonberger LB.
    Transfusion; 2024 Jun; 64(6):980-985. PubMed ID: 38650381
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion.
    Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG.
    Lancet; 2004 Feb 07; 363(9407):417-21. PubMed ID: 14962520
    [Abstract] [Full Text] [Related]

  • 6. Transfusion transmission of human prion diseases.
    Zou S, Fang CT, Schonberger LB.
    Transfus Med Rev; 2008 Jan 07; 22(1):58-69. PubMed ID: 18063192
    [Abstract] [Full Text] [Related]

  • 7. Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study.
    Urwin PJ, Mackenzie JM, Llewelyn CA, Will RG, Hewitt PE.
    Vox Sang; 2016 May 07; 110(4):310-6. PubMed ID: 26709606
    [Abstract] [Full Text] [Related]

  • 8. No evidence of transfusion transmitted sporadic Creutzfeldt-Jakob disease: results from a bi-national cohort study.
    Holmqvist J, Wikman A, Pedersen OBV, Nielsen KR, Rostgaard K, Hjalgrim H, Edgren G.
    Transfusion; 2020 Apr 07; 60(4):694-697. PubMed ID: 32187687
    [Abstract] [Full Text] [Related]

  • 9. Ten-year follow-up of two cohorts with an increased risk of variant CJD: donors to individuals who later developed variant CJD and other recipients of these at-risk donors.
    Checchi M, Hewitt PE, Bennett P, Ward HJ, Will RG, Mackenzie JM, Sinka K.
    Vox Sang; 2016 Nov 07; 111(4):325-332. PubMed ID: 27432362
    [Abstract] [Full Text] [Related]

  • 10. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ, Manjila S, Mehndiratta P, Khan F, Miller BR, Onwuzulike K, Puoti G, Cohen ML, Schonberger LB, Cali I.
    Neurosurg Focus; 2016 Jul 07; 41(1):E10. PubMed ID: 27364252
    [Abstract] [Full Text] [Related]

  • 11. The impact of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease on plasma safety.
    Hoots WK, Abrams C, Tankersleydagger D.
    Transfus Med Rev; 2001 Apr 07; 15(2 Suppl 1):45-59. PubMed ID: 11441420
    [Abstract] [Full Text] [Related]

  • 12. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP, Peckeu L, Haïk S.
    Transfus Clin Biol; 2013 Sep 07; 20(4):395-7. PubMed ID: 23587616
    [Abstract] [Full Text] [Related]

  • 13. Creutzfeldt-Jakob disease and blood transfusion.
    Esmonde TF, Will RG, Slattery JM, Knight R, Harries-Jones R, de Silva R, Matthews WB.
    Lancet; 1993 Jan 23; 341(8839):205-7. PubMed ID: 8093499
    [Abstract] [Full Text] [Related]

  • 14. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA, Turner ML.
    Br J Haematol; 2006 Jan 23; 132(1):13-24. PubMed ID: 16371015
    [Abstract] [Full Text] [Related]

  • 15. Variant CJD and blood transfusion: are there additional cases?
    Davidson LR, Llewelyn CA, Mackenzie JM, Hewitt PE, Will RG.
    Vox Sang; 2014 Oct 23; 107(3):220-5. PubMed ID: 24916465
    [Abstract] [Full Text] [Related]

  • 16. Infectious and Sporadic Prion Diseases.
    Knight R.
    Prog Mol Biol Transl Sci; 2017 Oct 23; 150():293-318. PubMed ID: 28838665
    [Abstract] [Full Text] [Related]

  • 17. Risk of transmission of Creutzfeldt-Jakob disease by transfusion of blood, plasma, and plasma derivatives.
    Vamvakas EC.
    J Clin Apher; 1999 Oct 23; 14(3):135-43. PubMed ID: 10540369
    [Abstract] [Full Text] [Related]

  • 18. Variant Creutzfeldt-Jakob disease.
    Ironside JW.
    Haemophilia; 2010 Jul 23; 16 Suppl 5():175-80. PubMed ID: 20590878
    [Abstract] [Full Text] [Related]

  • 19. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G, Llewelyn C, Mackenzie J, Cousens S, Kennedy A, Will R, Hewitt P.
    Transfusion; 2010 May 23; 50(5):1003-6. PubMed ID: 20230536
    [Abstract] [Full Text] [Related]

  • 20. Transmissible spongiform encephalopathy update and implications for blood safety.
    Ricketts MN, Brown P.
    Clin Lab Med; 2003 Mar 23; 23(1):129-37. PubMed ID: 12733428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.